OncoMed Pharmaceuticals, Inc. Net Profit Margin 2013-2018 | OMED
OncoMed Pharmaceuticals, Inc. net profit margin from 2013 to 2018. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2018-12-31 | $0.05B | $-0.01B | -20.00% |
| 2018-09-30 | $0.06B | $0.01B | 8.93% |
| 2018-06-30 | $0.04B | $-0.01B | -29.27% |
| 2018-03-31 | $0.04B | $-0.02B | -57.50% |
| 2017-12-31 | $0.04B | $-0.04B | -105.26% |
| 2017-09-30 | $0.02B | $-0.07B | -308.70% |
| 2017-06-30 | $0.02B | $-0.09B | -358.33% |
| 2017-03-31 | $0.03B | $-0.10B | -396.00% |
| 2016-12-31 | $0.03B | $-0.10B | -412.00% |
| 2016-09-30 | $0.03B | $-0.11B | -407.69% |
| 2016-06-30 | $0.03B | $-0.10B | -416.00% |
| 2016-03-31 | $0.02B | $-0.10B | -426.09% |
| 2015-12-31 | $0.03B | $-0.09B | -318.52% |
| 2015-09-30 | $0.03B | $-0.08B | -262.07% |
| 2015-06-30 | $0.04B | $-0.06B | -132.56% |
| 2015-03-31 | $0.04B | $-0.05B | -115.91% |
| 2014-12-31 | $0.04B | $-0.05B | -125.00% |
| 2014-09-30 | $0.05B | $-0.04B | -78.00% |
| 2014-06-30 | $0.04B | $-0.04B | -84.09% |
| 2014-03-31 | $0.04B | $-0.03B | -75.61% |
| 2013-12-31 | $0.04B | $-0.03B | -68.42% |
| 2013-09-30 | $0.03B | $-0.03B | -96.30% |
| 2013-06-30 | $0.02B | $-0.03B | -128.57% |
